The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 29, 2021
Filed:
Jul. 19, 2016
Applicant:
Veroscience Llc, Tiverton, RI (US);
Inventor:
Anthony H. Cincotta, Tiverton, RI (US);
Assignee:
VeroScience LLC, Tiverton, RI (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/42 (2006.01); A61K 31/44 (2006.01); A01N 43/58 (2006.01); A01N 43/60 (2006.01); A61K 31/48 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/24 (2006.01); A61K 9/70 (2006.01); A61K 31/00 (2006.01); A61K 31/135 (2006.01); A61K 31/485 (2006.01); A61K 31/4985 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01); A61K 47/44 (2017.01); A61K 9/06 (2006.01); A61K 9/16 (2006.01); A61K 31/366 (2006.01); A61K 31/403 (2006.01); A61K 31/55 (2006.01); A61K 9/12 (2006.01);
U.S. Cl.
CPC ...
A61K 31/48 (2013.01); A61K 9/006 (2013.01); A61K 9/0012 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 9/0056 (2013.01); A61K 9/06 (2013.01); A61K 9/1617 (2013.01); A61K 9/1635 (2013.01); A61K 9/1652 (2013.01); A61K 9/205 (2013.01); A61K 9/209 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2077 (2013.01); A61K 9/7007 (2013.01); A61K 31/00 (2013.01); A61K 31/135 (2013.01); A61K 31/366 (2013.01); A61K 31/403 (2013.01); A61K 31/485 (2013.01); A61K 31/4985 (2013.01); A61K 31/55 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A61K 47/44 (2013.01); A61K 9/0043 (2013.01); A61K 9/12 (2013.01);
Abstract
This invention relates to stable pharmaceutical compositions for parenteral administration comprising dopamine agonists and peripheral acting agents useful for treatment of metabolic disorders or key elements thereof. The parenteral dosage forms exhibit long stable shelf life and distinct pharmacokinetics.